Trichostatin A Induces NAG-1 Expression and Apoptosis in Human Endometriotic Stromal Cells

Seok Kyo Seo1,2, Jae Hoon Lee1,2, Seung Joo Chon3

  • 11 Department of Obstetrics and Gynecology, Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Republic of Korea.

Insights

Trichostatin A (TSA) induces apoptosis in human endometriotic stromal cells (HESCs) by upregulating nonsteroidal anti-inflammatory drug-activated gene 1 (NAG-1) expression. This suggests NAG-1 plays a key role in TSA-mediated cell death in endometriosis.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Endometriosis is a condition characterized by ectopic endometrial tissue, leading to inflammation and pain.
  • Nonsteroidal anti-inflammatory drug-activated gene 1 (NAG-1) is implicated in cellular stress responses and apoptosis.
  • Trichostatin A (TSA) is a histone deacetylase inhibitor with potential therapeutic applications.

Purpose of the Study:

  • To investigate the effect of TSA on NAG-1 expression and apoptosis in human endometriotic stromal cells (HESCs).
  • To elucidate the role of NAG-1 in TSA-induced apoptosis in HESCs.

Main Methods:

  • Human endometriotic stromal cells (HESCs) were isolated and treated with varying concentrations of TSA.
  • NAG-1 mRNA and protein levels were quantified using real-time PCR and Western blotting.
  • Apoptosis was assessed via flow cytometry; gene knockdown was performed using small-interfering RNA.

Main Results:

  • TSA reduced HESC viability and increased apoptosis in a dose-dependent manner.
  • TSA significantly induced NAG-1 mRNA and protein expression in HESCs.
  • Gene knockdown of NAG-1 attenuated TSA-induced apoptosis, confirming its role.

Conclusions:

  • TSA induces apoptosis in HESCs through the upregulation of NAG-1.
  • NAG-1 is a critical mediator of TSA's pro-apoptotic effects in endometriosis.
  • These findings highlight a potential therapeutic mechanism for endometriosis involving NAG-1 induction.